KLRS Latest Press Releases

-- August 11, 2026 --

Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 8:00 AM

-- August 3, 2026 --

KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders Globe Newswire 11:05 PM

-- July 20, 2026 --

Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer Globe Newswire 8:00 AM

-- July 17, 2026 --

Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts Globe Newswire 7:00 AM

-- July 6, 2026 --

Kalaris Appoints Laurie Keating to Board of Directors Globe Newswire 4:05 PM

-- June 23, 2026 --

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling Globe Newswire 8:00 AM

-- June 12, 2026 --

Kalaris to Present at Clinical Trials at the Summit 2026 Globe Newswire 8:00 AM

-- May 12, 2026 --

Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 8:00 AM

-- March 17, 2026 --

Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software